{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:23:00Z","timestamp":1759040580280},"reference-count":18,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2006,6,29]],"date-time":"2006-06-29T00:00:00Z","timestamp":1151539200000},"content-version":"vor","delay-in-days":4958,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[1992,12]]},"abstract":"<jats:p>A clear conceptual basis for anti\u2010sperm and other modes of immunological birth control exists in spite of the limited basic research done on surface antigens of sperm or egg. In the normal physiological condition, the immune system does not respond to sperm, egg or fetus. Compared with anti\u2010egg or anti\u2010fetus immunocontraception, an anti\u2010sperm vaccine has two theoretical advantages. First it would work in both males and females; second, it would not raise problems of autoimmunity in the female if a sperm\u2010specific protein is used.<\/jats:p><jats:p>However, for the development of such contraceptive vaccines the following scientific questions need to be resolved: (1) what surface protein to use as an antigen: (2) what adjuvant to use in humans for an anti\u2010fertility vaccine: (3) how to maintain a high titre; (4) how the contraceptive effect will be terminated; and (5) what are the potential side\u2010effects.<\/jats:p>","DOI":"10.1111\/j.1365-3083.1992.tb01633.x","type":"journal-article","created":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:04:19Z","timestamp":1151712259000},"page":"118-122","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti\u2010Sperm and Anti\u2010Ovum Vaccines: the Selection of Candidate Antigens and the Outcome of Preclinical Studies"],"prefix":"10.1111","volume":"36","author":[{"given":"M. A.","family":"ISAHAKIA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. S.","family":"BAMBRA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,29]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"205","volume-title":"Immunologic Aspects of Infertility and Fertility Regulation","author":"Menge AC.","year":"1980"},{"key":"e_1_2_1_3_2","first-page":"33","volume-title":"Immunologic Aspects of Infertility and Fertility Regulation","author":"Tung KSK.","year":"1980"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348109156938"},{"key":"e_1_2_1_5_2","first-page":"5","volume-title":"Immunological Factors in Human Reproduction Serona Symposium","author":"Schulman S.","year":"1982"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(68)90307-4"},{"key":"e_1_2_1_7_2","first-page":"359","article-title":"Studies on human spermatozoa autoantigens","volume":"44","author":"P'Almaida M","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0015-0282(16)47409-1","article-title":"A new look at antifertility vaccines","volume":"40","author":"Anderson DJ","year":"1983","journal-title":"Fertil Steril"},{"key":"e_1_2_1_9_2","first-page":"850","article-title":"Circulating antiovarian antibodies in premature ovarian failure","volume":"68","author":"Damewood MD","year":"1986","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(89)90094-4"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)60861-0"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-115-6-2418"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.1120160407"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0378(87)90089-1"},{"key":"e_1_2_1_15_2","first-page":"318","volume-title":"Methods m Enzymology","author":"Goldberg E.","year":"1975"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/335543a0"},{"key":"e_1_2_1_17_2","first-page":"37","volume-title":"Gamete Interaction: Prospects for Immunocontraception","author":"Lee CG","year":"1990"},{"key":"e_1_2_1_18_2","first-page":"293","volume-title":"Gamete Interaction: Prospects for Immunocontraception","author":"Aitken RJ","year":"1990"},{"key":"e_1_2_1_19_2","first-page":"313","volume-title":"Gamete Interaction: Prospects for Immunocontraception","author":"Dean J","year":"1990"}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3083.1992.tb01633.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3083.1992.tb01633.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:18:58Z","timestamp":1695809938000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3083.1992.tb01633.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,12]]},"references-count":18,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[1992,12]]}},"alternative-id":["10.1111\/j.1365-3083.1992.tb01633.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3083.1992.tb01633.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,12]]},"assertion":[{"value":"2006-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}